NYSE: NUSNu Skin Enterprises Revenue
Nu Skin Enterprises revenue was $1.56B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $364.2M, down 5.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NUS annual revenue was $1.7B, with -12% growth year-over-year.
NUS past revenue growth
How has NUS's revenue growth performed historically?
Company
-12.1%
Industry
2.65%
Market
22.91%
NUS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NUS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NUS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
NUS revenue history
Current Revenue
$1.6B
Current Earnings
$109.6M
Current Profit Margin
7%
NUS's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when NUS announces revenue.
NUS Revenue History By Year
| NUS Yearly Revenue | NUS Revenue | NUS Change | NUS Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $1.73B | -$237.05M | -12.04% |
| 2023-12-31 | $1.97B | -$256.53M | -11.53% |
| 2022-12-31 | $2.23B | -$470.01M | -17.44% |
| 2021-12-31 | $2.70B | $113.74M | +4.41% |
| 2020-12-31 | $2.58B | $161.52M | +6.67% |
| 2019-12-31 | $2.42B | -$258.59M | -9.65% |
| 2018-12-31 | $2.68B | $399.91M | +17.55% |
| 2017-12-31 | $2.28B | $71.30M | +3.23% |
| 2016-12-31 | $2.21B | -$39.25M | -1.75% |
| 2015-12-31 | $2.25B | -$322.45M | -12.55% |
| 2014-12-31 | $2.57B | -$607.22M | -19.11% |
| 2013-12-31 | $3.18B | $1.04B | +48.98% |
| 2012-12-31 | $2.13B | $412.67M | +24.00% |
| 2011-12-31 | $1.72B | $182.33M | +11.86% |
| 2010-12-31 | $1.54B | $206.20M | +15.49% |
| 2009-12-31 | $1.33B | $83.41M | +6.69% |
| 2008-12-31 | $1.25B | $89.98M | +7.77% |
| 2007-12-31 | $1.16B | $42.26M | +3.79% |
| 2006-12-31 | $1.12B | -$65.52M | -5.55% |
| 2005-12-31 | $1.18B | $43.07M | +3.78% |
| 2004-12-31 | $1.14B | $151.41M | +15.35% |
| 2003-12-31 | $986.46M | $22.39M | +2.32% |
| 2002-12-31 | $964.07M | $78.45M | +8.86% |
| 2001-12-31 | $885.62M | $5.86M | +0.67% |
| 2000-12-31 | $879.76M | -$14.49M | -1.62% |
| 1999-12-31 | $894.25M | -$19.25M | -2.11% |
| 1998-12-31 | $913.49M | -$39.93M | -4.19% |
| 1997-12-31 | $953.42M | $191.78M | +25.18% |
| 1996-12-31 | $761.64M | $403.03M | +112.39% |
| 1995-12-31 | $358.61M | $103.97M | +40.83% |
| 1994-09-30 | $254.64M | N/A | N/A |
Nu Skin Enterprises Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.